Your browser doesn't support javascript.
loading
Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison.
Van Sanden, Suzy; Ito, Tetsuro; Diels, Joris; Vogel, Martin; Belch, Andrew; Oriol, Albert.
Afiliación
  • Van Sanden S; Janssen Health Economics & Market Access EMEA Statistics & Modeling, Beerse, Belgium svsande1@its.jnj.com.
  • Ito T; Janssen Health Economics & Market Access EMEA, High Wycombe, United Kingdom.
  • Diels J; Janssen Health Economics & Market Access EMEA Statistics & Modeling, Beerse, Belgium.
  • Vogel M; Janssen EMEA Medical Affairs, Neuss, Germany.
  • Belch A; Department of Oncology, University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Oriol A; Institut Catala d'Oncologia, Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain.
Oncologist ; 23(3): 279-287, 2018 03.
Article en En | MEDLINE | ID: mdl-29192016
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos Monoclonales / Mieloma Múltiple Límite: Aged / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos Monoclonales / Mieloma Múltiple Límite: Aged / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article